We are live on ! Find out more
GCM

Garland Capital Management Portfolio holdings

AUM $7.27M
1-Year Est. Return 14.85%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$131M
AUM Growth
+$4.25M
Cap. Flow
-$1.97M
Cap. Flow %
-1.51%
Top 10 Hldgs %
40.2%
Holding
34
New
2
Increased
22
Reduced
7
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.47M
2
MON
Monsanto Co
MON
+$3.05M
3
CVX icon
Chevron
CVX
+$582K
4
PFE icon
Pfizer
PFE
+$542K
5
JNJ icon
Johnson & Johnson
JNJ
+$487K

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$4.36M
2
DLR icon
Digital Realty Trust
DLR
+$4.17M
3
GSK icon
GSK
GSK
+$3.81M
4
ITW icon
Illinois Tool Works
ITW
+$248K
5
MSFT icon
Microsoft
MSFT
+$126K

Sector Composition

Rank Sector Weight
1 Industrials 21.61%
2 Healthcare 18.11%
3 Consumer Staples 15.3%
4 Financials 13.14%
5 Real Estate 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.75T
$5.91M 4.52%
106,240
-2,405
-2% -$126K
ITW icon
2
Illinois Tool Works
ITW
$80.2B
$5.78M 4.42%
55,350
-2,675
-5% -$248K
JNJ icon
3
Johnson & Johnson
JNJ
$640B
$5.71M 4.37%
50,240
+4,700
+10% +$487K
MMM icon
4
3M
MMM
$92.2B
$5.47M 4.19%
38,721
-837
-2% -$108K
PFE icon
5
Pfizer
PFE
$160B
$5.25M 4.02%
166,671
+18,961
+13% +$542K
GE icon
6
GE Aerospace
GE
$356B
$5.12M 3.92%
34,329
+2,692
+9% +$380K
STJ
7
DELISTED
St Jude Medical
STJ
$5.11M 3.91%
83,850
-1,050
-1% -$57.2K
TRV icon
8
Travelers Companies
TRV
$77B
$4.78M 3.66%
41,250
-450
-1% -$49.1K
UL icon
9
Unilever
UL
$139B
$4.77M 3.65%
89,187
-2,231
-2% -$109K
JPM icon
10
JPMorgan Chase
JPM
$942B
$4.61M 3.53%
71,780
+900
+1% +$52.6K
RTX icon
11
RTX Corp
RTX
$286B
$4.51M 3.45%
67,890
+2,741
+4% +$159K
WM icon
12
Waste Management
WM
$87B
$4.33M 3.32%
76,400
+1,100
+1% +$60.7K
CVX icon
13
Chevron
CVX
$392B
$4.21M 3.22%
41,396
+6,655
+19% +$582K
PRU icon
14
Prudential Financial
PRU
$41.5B
$4.15M 3.18%
52,650
+3,150
+6% +$220K
PG icon
15
Procter & Gamble
PG
$333B
$4.15M 3.18%
50,900
+150
+0.3% +$12.1K
DRE
16
DELISTED
Duke Realty Corp.
DRE
$4.11M 3.15%
187,450
+5,500
+3% +$113K
PEP icon
17
PepsiCo
PEP
$191B
$4.08M 3.12%
39,790
-350
-0.9% -$34.6K
WMT icon
18
Walmart Inc
WMT
$817B
$4.06M 3.11%
176,025
+8,400
+5% +$184K
CSCO icon
19
Cisco
CSCO
$442B
$3.98M 3.05%
139,976
+2,500
+2% +$64.3K
HIW icon
20
Highwoods Properties
HIW
$3.46B
$3.86M 2.96%
81,975
+4,750
+6% +$207K
NVS icon
21
Novartis
NVS
$294B
$3.81M 2.92%
55,577
+1,507
+3% +$103K
ABBV icon
22
AbbVie
ABBV
$456B
$3.77M 2.89%
+62,335
New +$3.47M
IBM icon
23
IBM
IBM
$225B
$3.69M 2.83%
26,432
+993
+4% +$127K
BLK icon
24
Blackrock
BLK
$181B
$3.62M 2.77%
9,865
+620
+7% +$197K
LPT
25
DELISTED
Liberty Property Trust
LPT
$3.62M 2.77%
104,530
+9,350
+10% +$281K

Similar funds

Garland Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Garland Capital Management held 34 positions worth $131M, up 3.4% from $126M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Garland Capital Management's Q1 2016 filing shows 2 new, 22 increased, 7 reduced and 3 closed positions. Its largest new stake was AbbVie: 62,335 shares worth $3.77M. The largest sale was Du Pont De Nemours E I, an estimated $4.36M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Garland Capital Management's largest Q1 2016 buy was AbbVie: 62,335 shares worth $3.77M.
  • Garland Capital Management added most to Chevron in Q1 2016, an estimated $582K increase.
  • Garland Capital Management's biggest Q1 2016 reduction was Illinois Tool Works, cutting an estimated $248K.
  • Garland Capital Management fully exited Du Pont De Nemours E I in Q1 2016, selling an estimated $4.36M.
  • Garland Capital Management's ten largest holdings make up 40% of its $131M portfolio in Q1 2016.
  • Garland Capital Management opened 2 new positions and closed 3 in Q1 2016.
  • Garland Capital Management's portfolio value rose 3.4% quarter-over-quarter to $131M.

Based on Garland Capital Management's 13F filing for Q1 2016, filed 28 Apr 2016.